PLX 8-K 2026-08-12

Protalix BioTherapeutics, Inc. (PLX) 8-K dated 2026-08-12 — accession 0001104659-26-094433. This URL is the filing, not the PLX hub.

Protalix BioTherapeutics, Inc. (PLX) is a biotechnology company listed on US.

Protalix BioTherapeutics, Inc. filed a 8-K on 2026-08-12. Accession 0001104659-26-094433.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported PLX revenue for 2026-06-30 was $53.6M. Net income was $22.1M. Revenue was up 59.0% from 2026-03-31 to 2026-06-30. PLX currently screens at market cap $122.6M and trailing P/E 30.8.

Not investment advice. The PLX SEC hub lists recent forms. The stock page is the research view.